Cargando…

FDA eyes pharmacogenomics data.

Detalles Bibliográficos
Autor principal:	Wakefield, Julie
Formato:	Texto
Lenguaje:	English
Publicado:	2004
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1316888/ https://www.ncbi.nlm.nih.gov/pubmed/15040315

Ejemplares similares

Pharmacogenomic Biomarkers in US FDA-Approved Drug Labels (2000–2020)
por: Kim, Jeeyun A., et al.
Publicado: (2021)

Characterizing the Strength of Evidence in FDA Labels for Pharmacogenomic Biomarker-Guided Medication Use
por: Chin, Lauren, et al.
Publicado: (2017)

Rates of genetic testing in patients prescribed drugs with pharmacogenomic information in FDA-approved labeling
por: Young, John, et al.
Publicado: (2021)

Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information
por: Stanek, Eric J., et al.
Publicado: (2013)

Evidence for Treatment-by-Biomarker interaction for FDA-approved Oncology Drugs with Required Pharmacogenomic Biomarker Testing
por: Vivot, Alexandre, et al.
Publicado: (2017)

Detecting Signals in Pharmacogenomic Genome-Wide Association Studies
por: Wakefield, Jon, et al.
Publicado: (2014)

Exploring public genomics data for population pharmacogenomics
por: Lakiotaki, Kleanthi, et al.
Publicado: (2017)

OpenFDA: an innovative platform providing access to a wealth of FDA’s publicly available data
por: Kass-Hout, Taha A, et al.
Publicado: (2016)

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics
por: Mizzi, Clint, et al.
Publicado: (2016)

Pharmacogenomics
Publicado: (2008)

Pharmacogenomics
Publicado: (2008)

Pharmacogenomics in epilepsy
por: Balestrini, Simona, et al.
Publicado: (2018)

Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies
por: Hassan, Mubashir, et al.
Publicado: (2022)

Bringing FAIRness to FDA data through visualization
por: Espinoza Salomon, Juan
Publicado: (2023)

Enantiospecific Pharmacogenomics of Fluvastatin
por: Hirvensalo, Päivi, et al.
Publicado: (2019)

Clinical Application and Educational Training for Pharmacogenomics
por: Guy, Jason W., et al.
Publicado: (2020)

Pharmacogenomics arrives
por: Petsko, Gregory A
Publicado: (2004)

Pharmacogenomic Biomarkers
por: Kirkwood, Sandra C., et al.
Publicado: (2002)

Pharmacogenomics of Antibiotics
por: Stocco, Gabriele, et al.
Publicado: (2020)

Pharmacogenomics in Practice
por: Wang, Liewei, et al.
Publicado: (2019)

Pharmacogenomics and Morphine
por: Ofoegbu, Adaku, et al.
Publicado: (2021)

Assessment of pharmacogenomic agreement
por: Safikhani, Zhaleh, et al.
Publicado: (2016)

VARC consensus report: the FDA perspective(†)
por: Hillebrenner, Matthew G., et al.
Publicado: (2011)

Using Clinical Element Models for Pharmacogenomic Study Data Standardization
por: Zhu, Qian, et al.
Publicado: ( 201)

Pharmacogenomics of Viral Diseases
por: Dwivedi, Shailendra, et al.
Publicado: (2013)

Pharmacogenomics and Molecular Diagnostics
por: Banerjee, Ena Ray
Publicado: (2017)

Pharmacogenomics: The Genomics of Drug Response
por: March, Ruth
Publicado: (2000)

Pharmacogenomics: the promise of personalized medicine.
por: Hood, Ernie
Publicado: (2003)

5. Pharmacogenomics and Personalized Medicine
por: Topić, Elizabeta
Publicado: (2008)

Pharmacogenomics of pediatric asthma
por: Gupta, Sarika, et al.
Publicado: (2010)

6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
por: Stojiljkovic, Maja, et al.
Publicado: (2012)

Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics
por: Mizzi, Clint, et al.
Publicado: (2017)

Use of cell proliferation data in cancer risk assessment: FDA view.
por: Scheuplein, R J
Publicado: (1993)

Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies
por: Pozdeyev, Nikita, et al.
Publicado: (2016)

Assessing pharmacogenomic literacy in China through validation of the Chinese version of the Minnesota Assessment of Pharmacogenomic Literacy
por: Zhang, Lusi, et al.
Publicado: (2023)

Pharmacogenomics of antidepressant treatment effects
por: Licinio, Julio, et al.
Publicado: (2011)

Editorial: Big Data, Pharmacogenomics and Real-World Research in Pharmacology
por: Wei, James Cheng-Chung, et al.
Publicado: (2020)

Pharmacogenomics: methods and protocols
por: Lai, C
Publicado: (2006)

Pharmacogenomics in depression and antidepressants
por: Bondy, Brigitta
Publicado: (2005)

Clinical use of pharmacogenomics
por: Telenti, Amalio
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0tgvnganah68e3hegp1mcfrb9m